Merrill A/ McPeak insider trades: Iovance Biotherapeutics (IOVA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Merrill reports to the SEC






and 11 more companies
Open-market buys and sales
49 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | IOVA | ↑ Buy | 250,000 | $9.15 | $2.3M | Direct | Feb 20, 2024 (0d) |
| Sep 18, 2023 | IOVA | ↑ Buy | 10,000 | $5.56 | $56K | By Trust | Sep 19, 2023 (1d) |
| Dec 21, 2022 | IOVA | ↑ Buy | 10,000 | $6.15 | $62K | Direct | Dec 22, 2022 (1d) |
| Nov 29, 2022 | IOVA | ↑ Buy | 10,000 | $6.31 | $63K | By Trust | Nov 30, 2022 (1d) |
| Nov 28, 2022 | IOVA | ↑ Buy | 10,000 | $6.18 | $62K | By Trust | Nov 28, 2022 (0d) |
| May 31, 2022 | IOVA | ↑ Buy | 10,000 | $6.84 | $68K | Direct | Jun 2, 2022 (2d) |
| May 31, 2022 | IOVA | ↑ Buy | 10,000 | $6.80 | $68K | By Trust | Jun 2, 2022 (2d) |
| Dec 13, 2018 | IOVA | ↑ Buy | 10,000 | $9.63 | $96K | Direct | Dec 14, 2018 (1d) |
| Jun 24, 2016 | RSSS | ↑ Buy | 25,000 | $1.00 | $25K | Direct | Jun 27, 2016 (3d) |
| Mar 18, 2016 | RSSS | ↑ Buy | 10,000 | $0.75 | $8K | Direct | Mar 21, 2016 (3d) |
| Sep 16, 2015 | RSSS | ↓ Sell | 10,000 | $0.89 | $9K | Direct | Sep 17, 2015 (1d) |
| Aug 6, 2015 | RSSS | ↑ Buy | 10,000 | $0.88 | $9K | Direct | Aug 7, 2015 (1d) |
| Jun 18, 2015 | RSSS | ↑ Buy | 5,000 | $0.96 | $5K | Direct | Jun 22, 2015 (4d) |
| Jun 17, 2015 | RSSS | ↑ Buy | 10,000 | $0.96 | $10K | Direct | Jun 18, 2015 (1d) |
| May 20, 2015 | LLEX | ↑ Buy | 10,000 | $1.69 | $17K | Direct | May 21, 2015 (1d) |
| Mar 3, 2015 | RSSS | ↑ Buy | 15,000 | $0.96 | $14K | Direct | Mar 4, 2015 (1d) |
| Feb 25, 2015 | RSSS | ↑ Buy | 12,880 | $0.83 | $11K | Direct | Feb 25, 2015 (0d) |
| Feb 20, 2015 | RSSS | ↑ Buy | 9,600 | $0.75 | $7K | Direct | Feb 24, 2015 (4d) |
| Jan 29, 2015 | LLEX | ↑ Buy | 2,901 | $1.00 | $3K | Direct | Feb 9, 2015 (11d) |
| Dec 24, 2014 | RSSS | ↑ Buy | 4,600 | $0.85 | $4K | Direct | Feb 24, 2015 (62d) |
| Dec 19, 2014 | RSSS | ↑ Buy | 1,380 | $0.92 | $1K | Direct | Dec 24, 2014 (5d) |
| Dec 17, 2014 | RSSS | ↑ Buy | 2,248 | $0.90 | $2K | Direct | Dec 19, 2014 (2d) |
| Dec 16, 2014 | RSSS | ↑ Buy | 10,000 | $0.93 | $9K | Direct | Dec 17, 2014 (1d) |
| Dec 11, 2014 | RSSS | ↑ Buy | 2,500 | $0.84 | $2K | Direct | Dec 15, 2014 (4d) |
| Dec 3, 2014 | RSSS | ↑ Buy | 8,600 | $0.85 | $7K | Direct | Dec 5, 2014 (2d) |
| Dec 3, 2014 | RSSS | ↑ Buy | 4,600 | $0.84 | $4K | Direct | Dec 3, 2014 (0d) |
| Nov 25, 2014 | RSSS | ↑ Buy | 700 | $0.76 | $532 | Direct | Nov 28, 2014 (3d) |
| Nov 5, 2013 | LBIO | ↑ Buy | 50,000 | $2.00 | $100K | Direct | Nov 12, 2013 (7d) |
| Feb 22, 2013 | MILL | ↑ Buy | 5,000 | $3.94 | $20K | Held in family trust | Feb 26, 2013 (4d) |
| Jan 27, 2012 | MILL | ↑ Buy | 5,000 | $3.37 | $17K | Direct | Jan 31, 2012 (4d) |
| Jan 27, 2012 | MILL | ↑ Buy | 5,000 | $3.37 | $17K | Held in family trust | Jan 31, 2012 (4d) |
| Sep 26, 2011 | MILL | ↑ Buy | 5,000 | $3.09 | $15K | Direct | Sep 28, 2011 (2d) |
| Jul 21, 2011 | GNBP.OB | ↑ Buy | 10,000 | $1.40 | $14K | Direct | Sep 26, 2011 (67d) |
| Jan 26, 2011 | MILL | ↑ Buy | 4,501 | $5.00 | $23K | Direct | Jan 28, 2011 (2d) |
| Jan 24, 2011 | MILL | ↑ Buy | 5,499 | $5.00 | $27K | Direct | Jan 25, 2011 (1d) |
| Aug 20, 2010 | MILL | ↑ Buy | 10,000 | $4.45 | $45K | Direct | Aug 23, 2010 (3d) |
| Aug 9, 2010 | MILL | ↑ Buy | 7,500 | $4.88 | $37K | Held in family trust | Aug 9, 2010 (0d) |
| Dec 7, 2007 | QPCI | ↑ Buy | 5,000 | $0.70 | $4K | Direct | Dec 10, 2007 (3d) |
| Dec 4, 2007 | QPCI | ↑ Buy | 5,000 | $0.68 | $3K | Direct | Dec 6, 2007 (2d) |
| Nov 29, 2007 | MATH | ↑ Buy | 5,000 | $0.94 | $5K | Direct | Nov 30, 2007 (1d) |
| May 10, 2007 | MATH | ↑ Buy | 5,000 | $1.51 | $8K | Direct | May 10, 2007 (0d) |
| Mar 19, 2007 | DGTC.PK | ↑ Buy | 11,116 | $1.05 | $12K | Direct | Mar 30, 2007 (11d) |
| Dec 12, 2006 | MATH | ↑ Buy | 2,000 | $4.00 | $8K | Direct | Dec 13, 2006 (1d) |
| Nov 13, 2006 | MATH | ↑ Buy | 1,000 | $3.99 | $4K | Direct | Nov 15, 2006 (2d) |
| Nov 2, 2006 | DGTC.PK | ↑ Buy | 5,000 | $1.94 | $10K | Direct | Nov 6, 2006 (4d) |
| Sep 11, 2006 | DGTC.PK | ↑ Buy | 5,000 | $2.00 | $10K | Direct | Oct 3, 2006 (22d) |
| Apr 19, 2006 | TEK | ↓ Sell | 7,500 | $36.03 | $270K | Direct | Apr 20, 2006 (1d) |
| Oct 27, 2005 | MATH | ↑ Buy | 1,000 | $6.09 | $6K | Direct | Oct 27, 2005 (0d) |
| Jul 26, 2005 | GGBM | ↑ Buy | 10 | $700.00 | $7K | Direct | Jul 28, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Merrill A/ McPeak's insider trades
Merrill A/ McPeak is a director at Iovance Biotherapeutics (IOVA). Since Jul 26, 2005, Merrill has reported 47 open-market purchases worth $3.3M and 2 sales worth $279K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (92 filings), option exercises (11 filings), other transactions (7 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IOVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.